GLP-1 Therapy & Binge Eating Disorder
Binge eating disorder is a medical condition — not a lack of willpower. Emerging evidence suggests GLP-1 therapy can help quiet food noise, reduce cravings, and support recovery alongside behavioral treatment.
No commitment required. Assessment takes about 5 minutes.
What is binge eating disorder?
Binge eating disorder (BED) is characterized by recurrent episodes of consuming large amounts of food rapidly, often in secret, and feeling unable to stop. Episodes are accompanied by significant distress — shame, guilt, or disgust — but unlike bulimia, there is no purging.
BED has a strong neurobiological component. The same brain reward pathways involved in addiction are dysregulated in BED, which is why willpower-based approaches often fail. GLP-1 medications act on these pathways directly.
How GLP-1 therapy may help with BED
Quiets Food Noise
GLP-1 agonists act on brain reward pathways to reduce intrusive food thoughts and compulsive eating urges.
Reduces Cravings
By modulating dopamine signaling, GLP-1 therapy can reduce the intensity and frequency of food cravings.
Supports Weight Management
For patients with BED and obesity, GLP-1 therapy can support meaningful weight loss alongside behavioral treatment.
Research on GLP-1 therapy for BED is ongoing. Evidence is promising but not yet definitive. GLP-1 therapy should be considered as a complement to, not a replacement for, evidence-based psychological treatment such as CBT.
Common questions
Ready to take the next step?
Complete a free assessment. A licensed physician will review your information and determine whether GLP-1 therapy is appropriate for you.
This page is for informational purposes only and does not constitute medical advice. If you are struggling with an eating disorder, please also seek support from a qualified mental health professional.